Mateo, Francesca
He, Zhengcheng
Mei, Lin
de Garibay, Gorka Ruiz http://orcid.org/0000-0001-9936-8419
Herranz, Carmen
García, Nadia
Lorentzian, Amanda
Baiges, Alexandra
Blommaert, Eline
Gómez, Antonio http://orcid.org/0000-0001-5308-981X
Mirallas, Oriol http://orcid.org/0000-0002-8492-5195
Garrido-Utrilla, Anna http://orcid.org/0000-0002-8074-6739
Palomero, Luis
Espín, Roderic
Extremera, Ana I.
Soler-Monsó, M. Teresa
Petit, Anna
Li, Rong
Brunet, Joan http://orcid.org/0000-0003-1945-3512
Chen, Ke
Tan, Susanna
Eaves, Connie J. http://orcid.org/0000-0002-3452-1926
McCloskey, Curtis
Hakem, Razq
Khokha, Rama
Lange, Philipp F. http://orcid.org/0000-0003-1171-5864
Lázaro, Conxi http://orcid.org/0000-0002-7198-5906
Maxwell, Christopher A. http://orcid.org/0000-0002-0713-7136
Pujana, Miquel Angel http://orcid.org/0000-0003-3222-4044
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI18/01029, PI21/01306, CIBERONC, CIBERES)
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (SGR 2017-449, CERCA program)
Government of Catalonia | Departament de Salut, Generalitat de Catalunya (PERIS PFI-Salut SLT017-20-000076, PERIS Suport SLT017/20/000072)
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
Article History
Received: 20 May 2021
Accepted: 9 March 2022
First Online: 7 April 2022
Competing interests
: M.A.P. received an unrestricted research grant from Roche Pharma to develop the ProCURE ICO research program. The other authors declare no competing interests.